CN102988963A - Clinical research formula of diabetes mellitus - Google Patents
Clinical research formula of diabetes mellitus Download PDFInfo
- Publication number
- CN102988963A CN102988963A CN2013100083758A CN201310008375A CN102988963A CN 102988963 A CN102988963 A CN 102988963A CN 2013100083758 A CN2013100083758 A CN 2013100083758A CN 201310008375 A CN201310008375 A CN 201310008375A CN 102988963 A CN102988963 A CN 102988963A
- Authority
- CN
- China
- Prior art keywords
- clinical research
- ferrum
- echinacea
- spirulina
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a clinical research formula of diabetes mellitus and belongs to the medical field. The clinical research formula is characterized by being prepared by the following materials according to the preparation ratio: 4.85% of calcium, 7.37% of ferrum, 52.7% of enzyme, 17.6% of spirulina, 7% of echinacea and 5.27% of fetal bovine bone marrow, wherein the total content of the six materials is 11392mg.
Description
The present invention is a kind of clinical formulation for the treatment of diabetes, belongs to medical domain.
At medical domain, the method for diabetes is not also effectively effected a radical cure by each hospital with medicine at present.The present invention can be in 1～3 month, and the healing of diabetes is reached more than 90%.
Purpose of the present invention can reach by following measures:
The present invention is a kind of clinical formulation for the treatment of diabetes, belongs to medical domain: be characterized in that it is formulated by six kinds of materials such as calcium, ferrum, enzyme, spirulina, Echinacea, fetal bovine bone marrow.Its recipe ratio is that calcium contains 4.85%, ferrum contains 7.37%, enzyme contains 52.7%, spirulina contains 17.6%, Echinacea contains 7%, fetal bovine bone marrow contains 5.27%.Six kinds of composition total contents are: 11392mg.
The present invention compares with original technology that to have a cost low, makes simply, and good to the therapeutic effect of diabetes, effective percentage reaches more than 90%, and the healing expense is low, uses (directly warm water is oral) easy to carry, is a kind of prescription of desirable treatment diabetes.
Claims (2)
1. the present invention is a kind of clinical formulation for the treatment of diabetes, belongs to medical domain.Characteristics of the present invention are formulated by six kinds of compositions such as calcium, ferrum, enzyme, spirulina, Echinacea, fetal bovine bone marrow.Its characteristics are that its recipe ratio is: calcium contains 4.85%, ferrum contains 7.37%, enzyme contains 52.7%, spirulina contains 17.6%, Echinacea contains 7%, fetal bovine bone marrow contains 5.27%.Six kinds of composition total contents are: 11392mg.
2. a kind of clinical formulation for the treatment of diabetes according to claim 1, its characteristics are that best proportioning is: calcium 552mg; Ferrum 840mg; Enzyme 6000mg, spirulina 2000mg, Echinacea 800mg, fetal bovine bone marrow 600mg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100083758A CN102988963A (en) | 2013-01-10 | 2013-01-10 | Clinical research formula of diabetes mellitus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100083758A CN102988963A (en) | 2013-01-10 | 2013-01-10 | Clinical research formula of diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102988963A true CN102988963A (en) | 2013-03-27 |
Family
ID=47918397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100083758A Pending CN102988963A (en) | 2013-01-10 | 2013-01-10 | Clinical research formula of diabetes mellitus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102988963A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740601B (en) * | 2013-12-27 | 2018-08-03 | 烟台金子生物工程有限公司 | A kind of tire ox bone marrow piece and its production method |
-
2013
- 2013-01-10 CN CN2013100083758A patent/CN102988963A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740601B (en) * | 2013-12-27 | 2018-08-03 | 烟台金子生物工程有限公司 | A kind of tire ox bone marrow piece and its production method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015009499A (en) | Pharmaceutical compositions for treating thermal injuries and wounds combined with bone injuries. | |
| CN105726513A (en) | Far-infrared inflammation diminishing and pain alleviating patch | |
| CN102988963A (en) | Clinical research formula of diabetes mellitus | |
| CN103800785B (en) | Agent is wiped outside a kind of Chinese medicine for the treatment of comedo | |
| CN102784381A (en) | Clinical scientific prescription for treating cataract | |
| CN102327342A (en) | Snake oil liniment for preventing chilblain | |
| CN102451143A (en) | Foot protection cream for prevention and treatment of chapping | |
| CN102475869A (en) | Externally applied pharmaceutical composition for treating traumatic injury | |
| CN102793727A (en) | Clinical research formula for treating hyperactivity | |
| CN103505726A (en) | Clinical scientific research formula for heart disease | |
| CN102716415B (en) | External-use traditional Chinese medicine composition for treating body surface abscess | |
| CN105395574A (en) | Medicinal and edible compound squalene and fish oil soft capsule for preventing and treating cardiovascular and cerebtovascular disease | |
| CN102784291B (en) | A kind of liniment for the treatment of toothache with asthenic yin | |
| CN102836331A (en) | Traditional Chinese drug preparation for treating postpartum hypogalactia | |
| CN103550301B (en) | A kind of preparation being used for the treatment of bromhidrosis | |
| CN103211862A (en) | Medicinal liquid for treating beriberi | |
| CN105663881A (en) | Traditional Chinese medicine recipe for treating damp-heat type knee bursitis | |
| CN103566185A (en) | Traditional Chinese medicine combination for curing tinea of feet and hands and preparation method of same | |
| CN104274772A (en) | External ointment for treating chilblain | |
| CN104547003A (en) | Anti-allergy traditional Chinese medicine pills and preparation method | |
| CN102670786A (en) | Carbuncle furuncle eight-treasure pill | |
| CN102872196A (en) | Tincture medicament for treating wet beriberi | |
| CN1733075A (en) | Tinea treating drug | |
| CN1981834A (en) | Ointment for treating wound | |
| CN109395035A (en) | A kind of Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Fenghua Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Fenghua Document name: Notification of Publication of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Fenghua Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Fenghua Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130327 |